Literature DB >> 21859385

Sporotrichosis in HIV-infected patients: report of 21 cases of endemic sporotrichosis in Rio de Janeiro, Brazil.

Dayvison Francis Saraiva Freitas1, Brenda de Siqueira Hoagland, Antonio Carlos Francesconi do Valle, Beatriz Barros Fraga, Mônica Bastos de Barros, Armando de Oliveira Schubach, Rodrigo de Almeida-Paes, Tullia Cuzzi, Cláudia Maria Valete Rosalino, Rosely Maria Zancopé-Oliveira, Maria Clara Gutierrez-Galhardo.   

Abstract

Sporotrichosis is endemic in Rio de Janeiro, Brazil, and cases have been reported to be associated with HIV. This article describes the clinical manifestations and evolution of sporotrichosis in HIV-positive patients and constitutes the largest case series reported to date. There were 21 HIV-positive patients with sporotrichosis diagnosed by the recovery of the etiologic agent from 1999-2009. Sixteen patients (76.2%) were men and five (23.8%) were women, with a mean age of 41.2 years. Seven of these individuals were previously unaware of their HIV infection. Mean CD4 count was 346.4 cells/μl. The most frequent clinical presentations of sporotrichosis in these patients were the lymphocutaneous and disseminated form (seven patients each, 33.3%), followed by the widespread cutaneous form in five (23.8%), and fixed form in the remaining two (9.5%). In patients with the disseminated forms, clinical manifestations involved the skin in six, mucosa (nasal, oral, or conjunctival) in four, bone in two, and meninges in two. Eleven (52.4%) patients received itraconazole and eight (38.1%) amphotericin B contributing to an overall cure rate of 81%. Spontaneous cure was observed in one patient. The clinical forms of sporotrichosis varied according to the patients' immune status. The results demonstrate the importance of sporotrichosis as an opportunistic infection associated with AIDS in countries where the mycosis occurs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859385     DOI: 10.3109/13693786.2011.596288

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  29 in total

1.  Immune response against Sporothrix schenckii in TLR-4-deficient mice.

Authors:  Micheli Fernanda Sassá; Lucas Souza Ferreira; Livia Carolina de Abreu Ribeiro; Iracilda Zeppone Carlos
Journal:  Mycopathologia       Date:  2012-07       Impact factor: 2.574

2.  Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis.

Authors:  Dayvison F S Freitas; Suelen S Santos; Rodrigo Almeida-Paes; Manoel M E de Oliveira; Antonio C F do Valle; Maria Clara Gutierrez-Galhardo; Rosely M Zancopé-Oliveira; Joshua D Nosanchuk
Journal:  Virulence       Date:  2015       Impact factor: 5.882

3.  Evolution of virulence-related phenotypes of Sporothrix brasiliensis isolates from patients with chronic sporotrichosis and acquired immunodeficiency syndrome.

Authors:  Ingrid Ludmila Rodrigues Cruz; Dayvison Francis Saraiva Freitas; Priscila Marques de Macedo; Maria Clara Gutierrez-Galhardo; Antonio Carlos Francesconi do Valle; Marcos de Abreu Almeida; Rowena Alves Coelho; Fábio Brito-Santos; Maria Helena Galdino Figueiredo-Carvalho; Rosely Maria Zancopé-Oliveira; Rodrigo Almeida-Paes
Journal:  Braz J Microbiol       Date:  2020-05-22       Impact factor: 2.476

Review 4.  The impact of sporotrichosis in HIV-infected patients: a systematic review.

Authors:  José A S Moreira; Dayvison F S Freitas; Cristiane C Lamas
Journal:  Infection       Date:  2015-02-21       Impact factor: 3.553

5.  In Vitro and In Vivo Efficacy of Amphotericin B Combined with Posaconazole against Experimental Disseminated Sporotrichosis.

Authors:  Débora Nunes Mario; Josep Guarro; Janio Morais Santurio; Sydney Hartz Alves; Javier Capilla
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

6.  Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management.

Authors:  Rosane Orofino-Costa; Dayvison Francis Saraiva Freitas; Andréa Reis Bernardes-Engemann; Anderson Messias Rodrigues; Carolina Talhari; Claudia Elise Ferraz; John Verrinder Veasey; Leonardo Quintella; Maria Silvia Laborne Alves de Sousa; Rodrigo Vettorato; Rodrigo de Almeida-Paes; Priscila Marques de Macedo
Journal:  An Bras Dermatol       Date:  2022-09-22       Impact factor: 2.113

Review 7.  Epidemiology of Clinical Sporotrichosis in the Americas in the Last Ten Years.

Authors:  Rigoberto Hernández-Castro; Rodolfo Pinto-Almazán; Roberto Arenas; Carlos Daniel Sánchez-Cárdenas; Víctor Manuel Espinosa-Hernández; Karla Yaeko Sierra-Maeda; Esther Conde-Cuevas; Eder R Juárez-Durán; Juan Xicohtencatl-Cortes; Erika Margarita Carrillo-Casas; Jimmy Steven-Velásquez; Erick Martínez-Herrera; Carmen Rodríguez-Cerdeira
Journal:  J Fungi (Basel)       Date:  2022-05-30

8.  Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species.

Authors:  Geisa Ferreira Fernandes; Priscila Oliveira dos Santos; Anderson Messias Rodrigues; Alexandre Augusto Sasaki; Eva Burger; Zoilo Pires de Camargo
Journal:  Virulence       Date:  2013-01-16       Impact factor: 5.882

Review 9.  Molecular Components of the Sporothrix schenckii Complex that Induce Immune Response.

Authors:  Carlos A Alba-Fierro; Armando Pérez-Torres; Conchita Toriello; Yolanda Romo-Lozano; Everardo López-Romero; Estela Ruiz-Baca
Journal:  Curr Microbiol       Date:  2016-04-27       Impact factor: 2.188

Review 10.  Sporotrichosis: The Story of an Endemic Region in Peru over 28 Years (1985 to 2012).

Authors:  Max Carlos Ramírez Soto
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.